Transdermal plaster of aryl propionic non-steroid antiphlogistic

A technology of non-steroidal anti-inflammatory drugs and arylpropionic acids, applied in the field of medicine, can solve the problems of inconvenient use, large gastrointestinal side effects, short half-life, etc., and achieves that it is not easy to fall off or rub off, and the curative effect is lasting and stable. , the effect of improving stability

Inactive Publication Date: 2003-01-01
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Arylpropionic acid non-steroidal anti-inflammatory drugs, such as flurbiprofen, ketoprofen, ibuprofen, rosoprofen and naproxen, have antipyretic, analgesic and anti-inflammatory effects, and are widely used clinically For the treatment of arthritis, rheumatoid arthritis and chronic pain, etc., the commonly used dosage form of this type of drug is oral preparation. Due to the short half-life, it needs to be administered 3 to 4 times a day, and the side effects of the gastrointestinal tract are relatively large. Patients who need to take the drug for a long time Or gastric ulcer patients often cannot tolerate
[0003] Transdermal preparations can avoid the gastrointestinal irritation of oral drugs, reduce the systemic blood concentration, and increase the local drug concentration in the affected area, but the transdermal administration of aryl propionic acid NSAIDs Preparations such as ketoprofen are a gel preparation, which has defects such as uncertain dosage, inconvenient use and easy contamination of clothing
Transdermal patches can overcome the defects of gel preparations, but so far there is no report about arylpropionic acid NSAIDs made into transdermal patches

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Embodiment 1. prepare flurbiprofen transdermal patch, finished product flurbiprofen transdermal patch contains medicine 0.5mg / cm 2 .

[0008] Formula and ratio:

[0009] Flurbiprofen 2.5g High Molecular Weight Polyisobutylene 5.3g

[0010] Liquid paraffin 5.4g Low molecular weight polyisobutylene 2.8g

[0011] Resin 7.0g 2,6-di-tert-butyl-p-cresol 14mg

[0012] Azone 1.8g Medical Gasoline 100mL

[0013] Steps:

[0014] Add the non-polar polymer high-molecular-weight polyisobutene and low-molecular-weight polyisobutylene, plasticizer liquid paraffin and tackifier resin into medical gasoline according to the above ratio to completely swell, then add the drug flurbiprofen, the transdermal accelerator nitrogen Ketone and antioxidant 2,6-di-tert-butyl-p-cresol, stirred evenly, ultrasonically removed air bubbles, and then coated on the anti-adhesive layer on a coating machine as usual, dried while coating, and dried at 60°C Dried, then covered with a backing layer and t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to medicine technology and is especially one kind of new preparation form. The transdermal plaster is noe kind of antiphlogistic containing Flubiprofen, Ketoprofen, Ibuprofen, Rosorolfen, Naproxan and other aryl propionic non-steroid. It has three parts including non-sticking layer, medicine layer and lining layer. The medicine layer incldues medicine dispersed in matrix, and the matrix consists of non-polar polymer and plasticizer and may contains tackifier, transdermal promoter and oxidant. It has accurate admistration amount, no stimulation to gastrointestinaltract, relatively higher local medicine density in the affected part and controllable medicine release.

Description

Technical field: [0001] The invention relates to the technical field of medicine, in particular to a new dosage form of an aryl propionic acid non-steroidal anti-inflammatory drug—a transdermal patch. Background technique: [0002] Arylpropionic acid non-steroidal anti-inflammatory drugs, such as flurbiprofen, ketoprofen, ibuprofen, rosoprofen and naproxen, have antipyretic, analgesic and anti-inflammatory effects, and are widely used clinically For the treatment of arthritis, rheumatoid arthritis and chronic pain, etc., the commonly used dosage form of this type of drug is oral preparation. Due to the short half-life, it needs to be administered 3 to 4 times a day, and the side effects of the gastrointestinal tract are relatively large. Patients who need to take the drug for a long time Or gastric ulcer patients often cannot tolerate it. [0003] Transdermal preparations can avoid the gastrointestinal irritation of oral drugs, reduce the systemic blood concentration, and i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/70A61K31/192A61M37/00A61P29/00
Inventor 胡晋红陈琰
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products